Prednisone Plus Chloroquine for the Treatment of Hyper-reactive Malarial Splenomegaly

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 31, 2016

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions
Hyper-reactive Malarial SplenomegalyMalariaAnaemia
Interventions
DRUG

prednisone induction - chloroquine

At study entry, the patients will undergo physical examination and laboratory tests, including blood cell count, malaria microscopy, immune-chromatographic test for malaria antigen, malaria serology titers, and serum protein studies with immunoglobulin M quantification, immune-fixation and immunoglobulin free light chains measurement. We will assess all participants at 1, 3, 6 and 12 months after enrollment. Clinical examination and routine laboratory tests are done every 3 months during the follow-up period. Immunoglobulin M quantification and malaria serology are done at baseline, and at month 12 visit.

DRUG

Chloroquine

At study entry, the patients will undergo physical examination and laboratory tests, including blood cell count, malaria microscopy, immune-chromatographic test for malaria antigen, malaria serology titers, and serum protein studies with immunoglobulin M quantification, immune-fixation and immunoglobulin free light chains measurement. We will assess all participants at 1, 3, 6 and 12 months after enrollment. Clinical examination and routine laboratory tests are done every 3 months during the follow-up period. Immunoglobulin M quantification and malaria serology are done at baseline, and at month 12 visit.

Trial Locations (1)

Unknown

Lihir medical Centre, Londolovit

Sponsors
All Listed Sponsors
lead

Lihir Medical Centre

OTHER